Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity

Aim: Adult medulloblastomas (MB) are rare, and optimal post-craniospinal irradiation (CSI) chemotherapy is not yet defined. We investigated hematological toxicity in patients treated with platinum–etoposide (EP) post-CSI. Methods: Retrospective, single-institution study to determine hematological to...

Full description

Saved in:
Bibliographic Details
Main Authors: Edina Komlodi-Pasztor, Vasu Munjapara, Charles G Eberhart, Danielle A Bazer, Mohamed R Sherief, David Olayinka Kamson, Xiaobu Ye, Byram Hirsch Ozer, Matthias Holdhoff
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:CNS Oncology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.2217/cns-2023-0029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850220230448513024
author Edina Komlodi-Pasztor
Vasu Munjapara
Charles G Eberhart
Danielle A Bazer
Mohamed R Sherief
David Olayinka Kamson
Xiaobu Ye
Byram Hirsch Ozer
Matthias Holdhoff
author_facet Edina Komlodi-Pasztor
Vasu Munjapara
Charles G Eberhart
Danielle A Bazer
Mohamed R Sherief
David Olayinka Kamson
Xiaobu Ye
Byram Hirsch Ozer
Matthias Holdhoff
author_sort Edina Komlodi-Pasztor
collection DOAJ
description Aim: Adult medulloblastomas (MB) are rare, and optimal post-craniospinal irradiation (CSI) chemotherapy is not yet defined. We investigated hematological toxicity in patients treated with platinum–etoposide (EP) post-CSI. Methods: Retrospective, single-institution study to determine hematological toxicity in adult MB patients treated with EP (1995–2022). Results: Thirteen patients with a median follow-up of 50 months (range, 10–233) were analyzed. Four discontinued treatment due to toxicity, one after 1, 3 after 3 cycles. Hematological toxicities included grade 3 (5 patients) and grade 4 (6 patients). Two patients experienced post-treatment progression and died 16 and 37 months from diagnosis. Conclusion: Post-CSI EP demonstrates acceptable hematological toxicity in adult MB. However, the small cohort precludes definitive survival outcome conclusions. Prospective studies for comprehensive comparisons with other regimens are needed in this context.
format Article
id doaj-art-76c3189c2ee34db18a92af5c3fd23517
institution OA Journals
issn 2045-0907
2045-0915
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series CNS Oncology
spelling doaj-art-76c3189c2ee34db18a92af5c3fd235172025-08-20T02:07:09ZengTaylor & Francis GroupCNS Oncology2045-09072045-09152024-12-0113110.2217/cns-2023-0029Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicityEdina Komlodi-Pasztor0Vasu Munjapara1Charles G Eberhart2Danielle A Bazer3Mohamed R Sherief4David Olayinka Kamson5Xiaobu Ye6Byram Hirsch Ozer7Matthias Holdhoff8Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USADepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USADepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USADepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USAAim: Adult medulloblastomas (MB) are rare, and optimal post-craniospinal irradiation (CSI) chemotherapy is not yet defined. We investigated hematological toxicity in patients treated with platinum–etoposide (EP) post-CSI. Methods: Retrospective, single-institution study to determine hematological toxicity in adult MB patients treated with EP (1995–2022). Results: Thirteen patients with a median follow-up of 50 months (range, 10–233) were analyzed. Four discontinued treatment due to toxicity, one after 1, 3 after 3 cycles. Hematological toxicities included grade 3 (5 patients) and grade 4 (6 patients). Two patients experienced post-treatment progression and died 16 and 37 months from diagnosis. Conclusion: Post-CSI EP demonstrates acceptable hematological toxicity in adult MB. However, the small cohort precludes definitive survival outcome conclusions. Prospective studies for comprehensive comparisons with other regimens are needed in this context.https://www.tandfonline.com/doi/10.2217/cns-2023-0029adult medulloblastomacisplatincraniospinal radiationetoposidemedulloblastoma
spellingShingle Edina Komlodi-Pasztor
Vasu Munjapara
Charles G Eberhart
Danielle A Bazer
Mohamed R Sherief
David Olayinka Kamson
Xiaobu Ye
Byram Hirsch Ozer
Matthias Holdhoff
Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity
CNS Oncology
adult medulloblastoma
cisplatin
craniospinal radiation
etoposide
medulloblastoma
title Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity
title_full Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity
title_fullStr Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity
title_full_unstemmed Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity
title_short Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity
title_sort postradiation platinum etoposide in adult medulloblastomas retrospective analysis of hematological toxicity
topic adult medulloblastoma
cisplatin
craniospinal radiation
etoposide
medulloblastoma
url https://www.tandfonline.com/doi/10.2217/cns-2023-0029
work_keys_str_mv AT edinakomlodipasztor postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT vasumunjapara postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT charlesgeberhart postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT danielleabazer postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT mohamedrsherief postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT davidolayinkakamson postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT xiaobuye postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT byramhirschozer postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity
AT matthiasholdhoff postradiationplatinumetoposideinadultmedulloblastomasretrospectiveanalysisofhematologicaltoxicity